保荐人（主承销商）：中信证券股份有限公司

Group 1 - The core point of the article is the pricing and subscription details of the stock issuance by Shanghai Jianda Zhixin Medical Technology Group Co., Ltd, with a determined issuance price of 7.05 yuan per share, reflecting various financial metrics and investor participation [2][3][8]. Group 2 - After excluding invalid and highest bids, there were 278 participating investors, with a total subscription amount of 16,356,100,000 shares, resulting in a subscription multiple of 3,751.07 times [1][4]. - The determined issuance price corresponds to a price-to-earnings (P/E) ratio of 11.06 times based on the net profit attributable to the parent company for the year 2024, before non-recurring gains and losses [2][3]. - The company reported net profits of 191.32 million yuan for 2023 and 223.57 million yuan for 2024, meeting the listing standards of the Shenzhen Stock Exchange [3][6]. Group 3 - The effective subscription quantity from valid bids totaled 14,895,160,000 shares, with an effective subscription multiple of 3,416.02 times [4][11]. - The average static P/E ratio for the wholesale industry was reported at 25.73 times, indicating that the company's issuance price is significantly lower than the industry average [6][7]. - The strategic placement involved 6,300,000 shares allocated to the employee management plan, accounting for approximately 9.97% of the total issuance [8][10]. Group 4 - The subscription process for offline investors is set for September 16, 2025, with specific requirements for submitting bids and ensuring compliance with regulatory standards [12][13]. - The online subscription period is also scheduled for September 16, 2025, with a total initial issuance quantity of 10,110,500 shares available for public subscription [24][26]. - Investors must ensure their accounts meet the minimum market value requirements to participate in the online subscription [28][30].